OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel

OptimizeRx expands EHR programmatic reach via PulsePoint, adding 250,000 NPIs by November.

What the company is saying

OptimizeRx Corp. is announcing a partnership with PulsePoint to make its authenticated electronic health record (EHR) and e-prescribing inventory available to PulsePoint clients. The company frames this as a move to reduce fragmentation in healthcare professional (HCP) media planning, emphasizing easier integration of point of care inventory into broader media strategies. The announcement highlights that PulsePoint will add 250,000 incremental NPIs, bringing its programmatic EHR reach to over 1 million NPIs. CEO Stephen Silvestro positions the integration as removing barriers for brands and agencies, while PulsePoint’s Group Vice President of Sales, Keith Matt, claims the deal will offer clients more reach, control, and visibility. The release stresses the operational and scale benefits but does not mention any financial terms, revenue expectations, or contract values. The tone is confident and forward-looking, focusing on the anticipated operational impact rather than proven results.

What the data suggests

The partnership will add 250,000 incremental NPIs to PulsePoint’s platform, increasing its programmatic EHR reach to over 1 million NPIs. The integration is scheduled to make OptimizeRx’s authenticated EHR inventory available to PulsePoint advertisers in November 2026, a near-term milestone. The only quantitative disclosures are the NPI figures and the timing of programmatic access, with no financial metrics or adoption rates provided. The operational scope is clearly defined, but the announcement does not supply evidence for the claimed benefits such as reduced fragmentation or improved campaign performance. There is no data on revenue impact, client uptake, or realized efficiencies. The figures confirm a substantial increase in addressable HCPs, but the business impact remains unproven until after launch.

Analysis

The announcement is upbeat and emphasizes the strategic value of the partnership, highlighting expanded reach and the potential to reduce fragmentation in healthcare provider (HCP) media planning. However, most of the key claims are forward-looking, such as the expected availability of OptimizeRx’s EHR inventory in November 2026 and the anticipated benefits for marketers and clients. The only realised facts are the partnership itself, the operational integration plan, and the specific NPI figures. There is no disclosure of financial terms, revenue impact, or profitability metrics, which limits the ability to assess the true economic value of the deal. The language inflates the signal by asserting broad benefits (e.g., 'removes a layer of fragmentation', 'more reach, control, and visibility') without supporting evidence or usage data. The operational integration is expected in the near term (within a month), but the actual impact on business performance remains unproven.

Risk flags

• ●The announcement lacks financial disclosure, providing no information on expected revenue, costs, or profitability from the partnership. This makes it difficult to assess the economic value of the integration.
• ●The claimed benefits—such as reduced fragmentation and increased campaign effectiveness—are not supported by operational or usage data, leaving the real impact on marketing outcomes unproven.
• ●Adoption risk remains, as the integration’s success depends on PulsePoint clients actually utilizing the new inventory. Without evidence of client demand or early commitments, the scale benefits are still theoretical.

Bottom line

OptimizeRx’s partnership with PulsePoint will soon expand programmatic access to its EHR and e-prescribing inventory, adding 250,000 incremental NPIs and bringing PulsePoint’s reach to over 1 million NPIs. The integration is scheduled for November 2026, representing a near-term operational milestone. While the announcement quantifies the increase in addressable HCPs, it does not disclose any financial terms, revenue projections, or early client adoption data. The narrative is optimistic but relies on forward-looking claims about improved campaign integration and reduced fragmentation, without supporting evidence. Investors should watch for post-launch updates that provide concrete metrics on adoption, usage, and financial impact. The most important takeaway is that the operational scale will increase, but the business value will only become clear after real-world results are reported.

Announcement summary

(NASDAQ:OPRX) OptimizeRx Corp. announced a new partnership with PulsePoint, a programmatic platform focused on omnichannel healthcare marketing, to make OptimizeRx’s authenticated electronic health record (EHR) and e-prescribing inventory available to PulsePoint clients. The integration expands programmatic access to point of care inventory that was previously only available through direct or specialized channels. PulsePoint will bring this inventory and 250,000 incremental NPIs into its platform, which is designed for HCP media activation, optimization, and reporting. The partnership aims to reduce fragmentation in HCP media planning by making point of care inventory easier to incorporate into broader media plans, rather than managing it as a separate buy. The integration allows marketers to extend HCP campaigns into EHR and e-prescribing workflows within a connected programmatic strategy. Stephen Silvestro, CEO of OptimizeRx, stated that the partnership removes a layer of fragmentation, making it easier for brands and agencies to integrate point of care with other media investments. Keith Matt, Group Vice President of Sales at PulsePoint, commented that OptimizeRx extends the scale of in-workflow EHR engagement available to clients, providing more reach, control, and visibility across campaigns. PulsePoint is among the first DSPs to integrate OptimizeRx’s authenticated EHR inventory since OptimizeRx opened its network to programmatic buying in June 2026. The integration will give PulsePoint clients access to incremental NPIs through OptimizeRx’s point of care network and will bring PulsePoint’s programmatic EHR reach to over 1 million NPIs. OptimizeRx’s authenticated EHR inventory is expected to be available to advertisers using PulsePoint in November 2026. The announcement highlights the use of OptimizeRx’s Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) as part of its platform capabilities.

Disagree with this article?